OVERVIEW

A Virtual Reality Immune Dysregulation's Support of Malignant Pathophysiology: Focus on Solid Tumorigenesis and Associated Therapeutic Targets is organized by Med Learning Group and will be held from Nov 28, 2018 - Nov 28, 2019.

Target Audience:
This initiative is designed to meet the educational needs of oncologists, oncology pharmacists, oncology nurses, and other healthcare professional involved in the management of patients with cancer who are treated with or are eligible for treatment with immunotherapy.

Program Overview:
This case-based online activity will cover the treatment and management of patients with cancer who are treated with or are eligible for treatment with immunotherapy.

Accreditation Statement:
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity is planned and produced in accordance with ACCME Essentials.

Credit Designation Statement:
Med Learning Group designates this online activity for a maximum of 1.0 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the online activity.

Nursing Credit Information:
Purpose: This program would be beneficial for nurses involved in the long-term treatment and management of patients with cancer.
CNE Credits: 1.0 ANCC Contact Hour(s)

Learning Objectives:
Upon the completion of this program, attendees should be able to:
• Describe the complex interactions between cancer cells, the tumor microenvironment, and the immune system and the mechanism of action of immune checkpoints inhibitors
• Critically evaluate clinical data for checkpoint inhibition, with a focus on melanoma, non-small cell lung cancer, and head and neck squamous cell cancer
• Recognize and manage immune-related adverse events (irAEs) associated with novel cancer immunotherapies.